Aging-associated changes in the nuclear architecture, chromatin structure, altered expression and activity of chromatin remodeling factors, and the change in pattern of epigenetic marks (DNA methylation and histone modification) affect all cells in the adult body, including the population of stem cells (SCs) that is responsible for proper tissue rejuvenation. 1 The elucidation of these precise mechanisms will help to develop more efficient anti-aging strategies as well as facilitate a better understanding of age-related risks for cancer genesis.
Insulin-like growth factor-1 (Igf1), Insulin-like growth factor-2 (Igf2) and Insulin (Ins) are described as stimulators of proliferation of normal and malignant hematopoietic stem progenitor cells. 2 Although Igf1 and Igf2 signal through tyrosine kinase receptor Igf1R, Ins together with Igf2 may activate classical insulin receptor and all factors together may activate a hybrid Igf1R/insulin receptor. In contrast, Igf2R serves as a 'molecular bin' that prevents Igf2 from binding to Igf1R or insulin receptor. Activation of Igf1R and insulin receptor depending on cell type affects cell metabolism and/or proliferation. Addition of these factors in clonogenic assays may enhance survival of human CD34 þ hematopoietic stem progenitor cells and increase size of hematopoietic colonies, in particular, in erythroid lineage. 2 However, Ins factors as reported may stimulate proliferation of leukemic blasts.
On the other hand, it is well known that changes in Ins/Igf signaling have important implications for aging. 3 Accordingly, (i) Igf1 signaling negatively regulates lifespan in worms, flies and mammals, and (ii) Igf1 and Ins level in blood is regulated positively by caloric uptake. Although Ins is secreted after calorie uptake from pancreatic islands, Igf1 (known also as somatomedin-C) is secreted from liver into peripheral blood in growth hormone (GH) dependent manner.
Interestingly, expression of Igf2, Igf2R and Rasgrf1 (a small GTP exchange factor for Ras protein that is involved in Ins/Igf signaling) are regulated by changes in somatic imprinting. The imprinted genes have a crucial role in embryogenesis, fetal growth, the totipotential state of the zygote and the pluripotency of developmental early SCs. 4 The expression of imprinted genes is regulated by DNA methylation within differential methylated regions, which are CpG-rich cis-elements within their gene loci.
Recently, our group demonstrated the presence of pluripotent Oct4
À very small embryonic-like SCs (VSELs) in adult murine bone marrow (BM), 5 and postulated that these pluripotent SCs are deposited during early embryogenesis as a backup for long-term repopulating hematopoietic SCs. 6 In fact, as recently demonstrated BM-derived VSELs could be specified into hematopoietic lineage in co-cultures over OP-9 stroma cell support. 6 Furthermore, molecular analysis of VSELs revealed that their quiescence in adult BM and potentially premature depletion is controlled by epigenetic changes of some imprinted genes that regulate signaling of Ins/Igf (for example, Igf2-H19 locus, Igf2R and Rasgrf1).
7 Accordingly, we observed that murine BM-sorted VSELs erase the paternally methylated imprints (for example, at Igf2-H19 and Rasgrf1 loci); however, they hypermethylate the maternally methylated imprints (for example, Igf2R). 7 This epigenetic reprogramming of genomic imprinting negatively affects Ins/Igf signaling and maintains the quiescence of VSELs and protects them from premature aging and tumor formation.
Based on this, we became interested in a role of Ins/Igf signaling in homeostasis of a pool of BM VSELs and VSELsderived long-term repopulating hematopoietic stem cells. First, our studies performed on normal young (4-week-old) and old (2-year-old) mice revealed that the number of VSELs and their pluripotentiality decreased during ageing. 8 Accordingly, VSELs from old mice show lower expression of the pluripotentiality master-regulators, such as Oct4, Nanog, Sox2, Klf4 and cMyc ( Figure 1a ) and, at the molecular level, the Oct4 promoter in VSELs becomes hypermethylated with age and shows a closed chromatin structure (Figure 1b) . Furthermore, VSELs from old mice show the somatic type of methylation at both Igf2-H19 and Rasgrf1 loci, which suggests that VSELs from old mice have increased sensitivity to Ins factors signaling (Figure1c and Supplementary Figure 1 ). This suggests that chronic Ins/Igf signaling in VSELs may contribute to age-related depletion of these cells.
Thus, to test the hypothesis that chronic Ins/Igf signaling may accelerate depletion of the pool of VSELs in adult BM, we became interested in Laron dwarf mice. Owing to a deficiency of GH receptor, these animals display a severe reduction in the 
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Igf1 plasma level and do not display increase in GH-mediated Igf-1 plasma level in response to caloric uptake. 9 Interestingly, these animals live 30-40% longer than their normal littermates. 10 Several possible explanations of this effect have been proposed, but we became interested in whether a reduced level of Igf1 in the plasma of these animals may directly impact/ protect the survival of VSELs in adult murine BM.
To address this issue, we measured the number of VSELs in BM of 8-month and 20-month-old murine Laron dwarfs (GHR À/À ) and corresponding normal heterozygous littermates (GHR þ /À ) by FACS. Interestingly, we noticed that the number of VSELs in the BM of plasma Igf1-deficient Laron dwarfs is maintained at a three-to four-fold higher level than normal GHR þ /À littermates during aging (Figure 2a) . Our molecular analysis studies have additionally demonstrated that the Oct4 promoter in these animals shows also a higher level of demethylation (Figure 2b) . Furthermore, while analysis of peripheral blood cell counts did not reveal any differences in the number of erythrocytes, platelets and leukocytes between Laron dwarf mice and wild-type controls, and all these mice have normal histology of bone marrow tissue (data not shown), we observed that Laron dwarf mice have in BM: (i) a approximately threefold increase in the number of Sca-1 þ c-kit þ lineage -hematopoietic SCs (8-month olds) and (ii) up to fourfold higher number of clonogenic CFU-GM, BFU-E and CFU-Meg cells (8-and 20-month old) ( Figure 2c ). As the plasma Igf1 level is regulated in mice by caloric uptake and in humans by caloric uptake providing that protein uptake is also low, 11 these data shed new light on caloric restriction, senescence and the size of hematopoietic SC compartment. Based on this, we propose a new paradigm in which chronic Igf1 deficiency somehow protects VSELs from age-related elimination from BM. This mimics a situation seen in chronic caloric restriction in mice, where the Igf1 level is low and longevity is extended Since the long-living Laron dwarf mice that have extremely low levels of circulating Igf1 have higher numbers of VSELs and hematopoietic stem progenitor cells in BM, we postulate that chronically elevated levels of Igf1 resulting, for example, from high caloric uptake may lead to premature depletion of the SC pool, including VSELs and hematopoietic stem progenitor cells, and thus be responsible for premature aging in mice. This hypothesis is currently being Letters to the Editor tested in mice that overexpress GH and thus have high plasma Igf1 level, and interestingly, in contrast to the long-lived Laron dwarf mice (GHR À/À ), show a markedly reduced life span. 12 Further studies are needed to link the effect of chronic high Igf1 signaling in VSELs with the development of cancer. Of note, both murine Laron dwarfs and human Laron dwarfs with chronically low Igf1 levels are significantly protected from developing solid cancer and leukemia. 13 As many human malignancies are activated by Igf1 and Igf2 signaling (for example, because of loss of heterozygosity or loss of imprinting at the Igf2-H19 locus), 14 we hypothesize that excessive activation of VSELs in an Ins/Igf-dependent manner could promote malignant transformation of these cells. However, the hypothetical reverse effect of low Ins/Igf signaling on a pool of VSELs that could become cancer/leukemia initiating cells requires further experimental study.
On the basis of our data, we postulate novel linkages between the Igf1 level, aging and the SC compartment (Figure 3 ). According to our hypothesis, early in development a population of VSELs would be deposited in developing organs as a backup for tissue-committed SCs that has a role in rejuvenation of tissues and organ regeneration after damage. 5 These cells seem to be protected from uncontrolled proliferation and age-related depletion by changes in imprinted genes that regulate Ins signaling. 7 We hypothesize that the pool of VSELs residing in adult tissues including BM is regulated by the circulating Igf1 level. An increase in Igf1 level (for example, resulting from a chronically high caloric uptake) would accelerate in an Ins/Igfdependent manner, an age-dependent depletion of the pool of VSELs and their potential to rejuvenate tissues (for example, in BM to supply long-term repopulating hematopoietic stem cells). By contrast, a low Igf1 level (for example, as seen in Laron dwarf mutants or as a result of caloric restriction) would have an opposite and protective effect on these cells.
Thus, we present for the first time a hypothesis that relates aging, longevity, Ins factor signaling and high caloric uptake to the abundance and function of pluripotent VSELs deposited in adult tissues. A decrease in the number of these cells will affect pools of TCSCs and have an impact on tissue rejuvenation and life span. Chromosomal rearrangements are frequently found in hematological malignancies. 1 Transgenic expression of the generated aberrant transcripts and corresponding fusion proteins often induces leukemia in mice, suggesting a role in disease onset. 2 The MYB gene, on human chromosome 6, corresponds to a 75-kDa transcription factor exerting a physiological function in the hematopoietic system (reviewed in Ramsay and Gonda 3 ). GATA1, a nuclear protein with an essential role in hematopoiesis, is coded by a gene located on the human X chromosome (reviewed in Shimizu et al. ). A specific and complementary cross talk between these two factors has been observed in hematopoietic maturation. High levels of MYB and low levels of GATA1 characterize the early stages of hematopoiesis: as differentiation progresses, an inverse regulation takes place ultimately leading to high levels of GATA1 and low levels of MYB in terminally differentiated cells. 3 The role of MYB and GATA1 has been explored through various in vivo studies. Several animal models that expressed reduced levels of GATA1 were used to study the effects of its deficiency. Interestingly, expression of the GATA1 low allele, as obtained in one GATA1 genetically impaired mouse model, results in anemia and thrombocytopenia, 5 and eventually into a disease closely resembling human idiophatic myelofibrosis. 6 We identified in an acute myeloid leukemia-M5 patient (see Supplementary Information) a rare chromosomal rearrangement (t(X;6)(p11.2; q23)), which results in a MYB-GATA1 fusion product. We have studied this aberrant product in mice expressing reduced levels of GATA1 and found that it is able to induce leukemia, although with reduced penetrance and long latency.
To characterize this genomic alteration, we carried out fluorescence in situ hybridization as well as 3 0 -rapid amplification of cDNA ends PCR experiments, precisely positioning the two breakpoints (bps) and cloning a MYB-GATA1 fusion transcript (Figure 1i ; for details see the Supplementary Materials and Supplementary Figure 1) . We observed that an X chromosome internal inversion, associated with its translocation to chromosome 6, had occurred, as explained and illustrated in Supplementary Figure 2 . Owing to GATA1 localization on the X chromosome and the fact that our patient was a male, the rearrangement resulted in the creation of the aberrant fusion transcript, complete loss of the normal GATA1 gene, and lack of a reciprocal fusion transcript, as one would expect in the
